The Oncosearch | Oncotarget

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers Research Paper

Yosuke Osawa, Ekumi Kojika, Koji Nishikawa, Masamichi Kimura, Shigenori Osakaya, Hiromi Miyauchi, Tatsuya Kanto, Yutaka Kawakami, Kiminori Kimura

Published Apr 30, 2019 · Vol. 10, No. 32 · pp. 3013-3026

Keywords: PD-L1, β-catenin, CBP, colon cancer, metastatic liver cancer

Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung Research Paper

Kayla J. Meade, Francesca Sanchez, Analine Aguayo, Nathalie Nadales, Sarkis G. Hamalian, Toni L. Uhlendorf, Lisa R. Banner, Jonathan A. Kelber

Published Apr 30, 2019 · Vol. 10, No. 32 · pp. 3027-3039

Keywords: premetastatic niche, tumor microenvironment, metastasis, breast cancer secretomes, LCN2

Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells Research Paper

María Celeste Díaz Flaqué, Maria Florencia Cayrol, Helena Andrea Sterle, María del Rosario Aschero, Johanna Abigail Díaz Albuja, Blanca Isse, Ricardo Norberto Farías, Leandro Cerchietti, Cinthia Rosemblit, Graciela Alicia Cremaschi

Published Apr 30, 2019 · Vol. 10, No. 32 · pp. 3051-3065

Keywords: thyroid hormones, CYP 450, integrin αvβ3, doxorubicin, T-cell lymphoma

Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins Research Paper

Nicole E. James, Evelyn Cantillo, Naohiro Yano, Clinton O. Chichester, Paul A. DiSilvestro, Virginia Hovanesian, R. Shyama Prasad Rao, Kyukwang K. Kim, Richard G. Moore, Nagib Ahsan, Jennifer R. Ribeiro

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2959-2972

Keywords: ovarian cancer, proteomics, septin-2, metabolic proteins

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

Di (Maria) Jiang, Anthony Fyles, Linh T. Nguyen, Benjamin G. Neel, Adrian Sacher, Robert Rottapel, Ben X. Wang, Pamela S. Ohashi, Srikala S. Sridhar

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2947-2958

Keywords: radiation, immunotherapy, breast cancer, anti-CTLA-4

P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines Research Paper

Elpetra Timmermans-Sprang, Rob Collin, Arjen Henkes, Meike Philipsen, Jan A. Mol

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2930-2946

Keywords: cancer stem cell, canine mammary tumor exome-sequencing, CDH3, Wnt, cSRC

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk Research Paper

Erika J. Lampert, John L. Hays, Elise C. Kohn, Christina M. Annunziata, Lori Minasian, Minshu Yu, Nicolas Gordon, Tristan M. Sissung, Victoria L. Chiou, William D. Figg, Nicole Houston, Jung-Min Lee

Published Apr 23, 2019 · Vol. 10, No. 30 · pp. 2855-2868

Keywords: high-grade serous ovarian cancer, BRCA wild type, olaparib, carboplatin

Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes Correction

Tina Huang, Roxanna Garcia, Jin Qi, Rishi Lulla, Craig Horbinski, Amir Behdad, Nitin Wadhwani, Ali Shilatifard, Charles James, Amanda M. Saratsis

Published Apr 12, 2019 · Vol. 10, No. 28 · pp. 2788-2788

BCR: a promiscuous fusion partner in hematopoietic disorders Review

Malalage N. Peiris, Fangda Li, Daniel J. Donoghue

Published Apr 12, 2019 · Vol. 10, No. 28 · pp. 2738-2754

Keywords: oncogenic fusion protein, chromosomal translocation, leukemia, breakpoint cluster region, RTK

Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells Research Paper

Sarah Beaudin, Leila Kokabee, JoEllen Welsh

Published Mar 19, 2019 · Vol. 10, No. 23 · pp. 2292-2305

The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes Research Paper

Yuichi Murakami, Yoshizo Kimura, Akihiko Kawahara, Shohei Mitsuyasu, Hidetoshi Miyake, Kaoru Tohyama, Yoshio Endo, Nao Yoshida, Yutaka Imamura, Kosuke Watari, Mayumi Ono, Takashi Okamura, Michihiko Kuwano

Published Mar 19, 2019 · Vol. 10, No. 23 · pp. 2270-2281

Keywords: myelodysplastic syndromes, cytidine deaminase, 5-azacytidine, DNA methylation, hypomethylating agent

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models Research Paper

Leah A. Mitchell, Kader Yagiz, Andrew Hofacre, Sophie Viaud, Anthony W. Munday, Fernando Lopez Espinoza, Daniel Mendoza, Maria E. Rodriguez-Aguirre, Simon Bergqvist, Ali Haghighi, Marin V. Miner, William P. Accomando, Cynthia Burrascano, Dawn Gammon, Harry E. Gruber, Douglas J. Jolly, Amy H. Lin

Published Mar 19, 2019 · Vol. 10, No. 23 · pp. 2252-2269

Keywords: immunotherapy, single chain variable fragment, retroviral replicating vector, PD-L1, PD-1

Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model Research Paper

Nir Pillar, Avital Luba Polsky, Noam Shomron

Published Mar 12, 2019 · Vol. 10, No. 21 · pp. 2086-2094

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, Cheryl Jorcyk

Published Mar 12, 2019 · Vol. 10, No. 21 · pp. 2068-2085

Keywords: oncostatin M, interleukin-6 and oncostatin M, interleukin-1β, breast cancer, metastasis

Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil Research Paper

Eloisa González-Lavado, Lourdes Valdivia, Almudena García-Castaño, Fernando González, Carmen Pesquera, Rafael Valiente, Mónica L. Fanarraga

Published Mar 12, 2019 · Vol. 10, No. 21 · pp. 2022-2029

Keywords: nanomaterial, nanocarrier, drug delivery, combined therapy, microtubule dynamics

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma Research Paper

Carla M.L. van Herpen, Sanjiv S. Agarwala, Axel Hauschild, Carola Berking, J. Thaddeus Beck, Dirk Schadendorf, Rob Jansen, Paola Queirolo, Paolo A. Ascierto, Christian U. Blank, Michael C. Heinrich, Rupam R. Pal, Adnan Derti, Victor Antona, Heidi Nauwelaerts, Angela Zubel, Reinhard Dummer

Published Mar 5, 2019 · Vol. 10, No. 19 · pp. 1850-1859

CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition Research Paper

Jasmin B. Post, Nizar Hami, Alexander E.E. Mertens, Suraya Elfrink, Johannes L. Bos, Hugo J.G. Snippert

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1440-1457

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, Cheryl Jorcyk

Published Feb 14, 2019

Keywords: Oncostatin M, Interleukin-6, interleukin-1β, breast cancer, metastasis

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, Cheryl Jorcyk

Published Feb 14, 2019

Keywords: Oncostatin M, Interleukin-6, interleukin-1β, breast cancer, metastasis

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Editorial

Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, Cheryl Jorcyk

Published Feb 13, 2019

Keywords: Oncostatin M, Interleukin-6, interleukin-1β, breast cancer, metastasis

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers Research Paper

Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung Research Paper

Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells Research Paper

Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins Research Paper

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines Research Paper

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk Research Paper

Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes Correction

BCR: a promiscuous fusion partner in hematopoietic disorders Review

Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells Research Paper

The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes Research Paper

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models Research Paper

Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil Research Paper

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma Research Paper

CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Editorial

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers Research Paper

Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung Research Paper

Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells Research Paper

Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins Research Paper

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines Research Paper

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk Research Paper

Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes Correction

BCR: a promiscuous fusion partner in hematopoietic disorders Review

Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells Research Paper

The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes Research Paper

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models Research Paper

Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil Research Paper

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma Research Paper

CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Research Paper

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β Editorial